Tomas Kron

Author PubWeight™ 52.59‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Cancer risk after medical exposure to radioactive iodine in benign thyroid diseases: a meta-analysis. Endocr Relat Cancer 2012 1.50
2 Implementation of a lung radiosurgery program: technical considerations and quality assurance in an Australian institution. J Med Imaging Radiat Oncol 2012 1.44
3 Ionization chamber volume determination and quality assurance using micro-CT imaging. Phys Med Biol 2008 1.39
4 Imaging cellular proliferation during chemo-radiotherapy: a pilot study of serial 18F-FLT positron emission tomography/computed tomography imaging for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2009 1.21
5 The impact of time between staging PET/CT and definitive chemo-radiation on target volumes and survival in patients with non-small cell lung cancer. Radiother Oncol 2013 1.13
6 Online adaptive radiotherapy for muscle-invasive bladder cancer: results of a pilot study. Int J Radiat Oncol Biol Phys 2010 1.13
7 Simultaneous infield boost with helical tomotherapy for patients with 1 to 3 brain metastases. Am J Clin Oncol 2007 1.11
8 Acute toxicity in prostate cancer patients treated with and without image-guided radiotherapy. Radiat Oncol 2011 1.06
9 A prospective evaluation of helical tomotherapy. Int J Radiat Oncol Biol Phys 2007 1.05
10 Consideration of the radiation dose delivered away from the treatment field to patients in radiotherapy. J Med Phys 2011 0.98
11 The clinical significance and management of lesion motion due to respiration during PET/CT scanning. Cancer Imaging 2011 0.95
12 High rates of tumor growth and disease progression detected on serial pretreatment fluorodeoxyglucose-positron emission tomography/computed tomography scans in radical radiotherapy candidates with nonsmall cell lung cancer. Cancer 2010 0.92
13 A comparison of prostate IMRT and helical tomotherapy class solutions. Radiother Oncol 2006 0.91
14 Variations in dose response with x-ray energy of LiF:Mg,Cu,P thermoluminescence dosimeters: implications for clinical dosimetry. Phys Med Biol 2004 0.90
15 Tomotherapy planning of small brain tumours. Radiother Oncol 2005 0.90
16 Validation of a 4D-PET maximum intensity projection for delineation of an internal target volume. Int J Radiat Oncol Biol Phys 2013 0.89
17 Introduction of online adaptive radiotherapy for bladder cancer through a multicentre clinical trial (Trans-Tasman Radiation Oncology Group 10.01): Lessons learned. J Med Phys 2013 0.85
18 A dosimetric comparison of 3D conformal vs intensity modulated vs volumetric arc radiation therapy for muscle invasive bladder cancer. Radiat Oncol 2012 0.85
19 Plan of the day selection for online image-guided adaptive post-prostatectomy radiotherapy. Radiother Oncol 2013 0.84
20 An analysis of respiratory induced kidney motion on four-dimensional computed tomography and its implications for stereotactic kidney radiotherapy. Radiat Oncol 2013 0.84
21 Successful implementation of image-guided radiation therapy quality assurance in the Trans Tasman Radiation Oncology Group 08.01 PROFIT Study. Int J Radiat Oncol Biol Phys 2010 0.84
22 Late toxicity and biochemical control in 554 prostate cancer patients treated with and without dose escalated image guided radiotherapy. Radiother Oncol 2013 0.83
23 Intrafraction bladder motion in radiation therapy estimated from pretreatment and posttreatment volumetric imaging. Int J Radiat Oncol Biol Phys 2013 0.83
24 Comparison of CT on rails with electronic portal imaging for positioning of prostate cancer patients with implanted fiducial markers. Int J Radiat Oncol Biol Phys 2009 0.83
25 Seminal vesicle interfraction displacement and margins in image guided radiotherapy for prostate cancer. Radiat Oncol 2012 0.83
26 Motion-induced dose artifacts in helical tomotherapy. Phys Med Biol 2009 0.82
27 Vacuum immobilisation reduces tumour excursion and minimises intrafraction error in a cohort study of stereotactic ablative body radiotherapy for pulmonary metastases. J Med Imaging Radiat Oncol 2013 0.82
28 High-resolution imaging of pulmonary ventilation and perfusion with 68Ga-VQ respiratory gated (4-D) PET/CT. Eur J Nucl Med Mol Imaging 2013 0.81
29 The detectability and localization accuracy of implanted fiducial markers determined on in-room computerized tomography (CT) and electronic portal images (EPI). Med Dosim 2008 0.81
30 Multimodality guidance for accurate bronchoscopic insertion of fiducial markers. J Thorac Oncol 2015 0.81
31 A contemporary review of stereotactic radiotherapy: inherent dosimetric complexities and the potential for detriment. Acta Oncol 2011 0.81
32 Variations in cone beam CT numbers as a function of patient size: in vivo demonstration in bladder cancer patients. J Med Imaging Radiat Oncol 2010 0.80
33 An automated voxelized dosimetry tool for radionuclide therapy based on serial quantitative SPECT/CT imaging. Med Phys 2013 0.80
34 Investigation of dose homogeneity for loose helical tomotherapy delivery in the context of breath-hold radiation therapy. Phys Med Biol 2005 0.80
35 A randomised study of a diet intervention to maintain consistent rectal volume for patients receiving radical radiotherapy to the prostate. Acta Oncol 2013 0.79
36 Does inverse-planned intensity-modulated radiation therapy have a role in the treatment of patients with left-sided breast cancer? J Med Imaging Radiat Oncol 2011 0.79
37 An optimized online verification imaging procedure for external beam partial breast irradiation. Med Dosim 2010 0.79
38 Effect of different breathing patterns in the same patient on stereotactic ablative body radiotherapy dosimetry for primary renal cell carcinoma: a case study. Med Dosim 2013 0.79
39 A prospective observational study of Gallium-68 ventilation and perfusion PET/CT during and after radiotherapy in patients with non-small cell lung cancer. BMC Cancer 2014 0.79
40 Asymmetric fan beams (AFB) for improvement of the craniocaudal dose distribution in helical tomotherapy delivery. Med Phys 2004 0.78
41 A feasibility study of using couch-based real time dosimetric device in external beam radiotherapy. Med Phys 2011 0.78
42 Benchmarking dosimetric quality assessment of prostate intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2011 0.78
43 Australasian brachytherapy audit: results of the 'end-to-end' dosimetry pilot study. J Med Imaging Radiat Oncol 2013 0.78
44 CT perfusion imaging in response assessment of pulmonary metastases undergoing stereotactic ablative radiotherapy. J Med Imaging Radiat Oncol 2015 0.78
45 An in vivo investigative protocol for HDR prostate brachytherapy using urethral and rectal thermoluminescence dosimetry. Radiother Oncol 2008 0.78
46 A comparison of in-room computerized tomography options for detection of fiducial markers in prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys 2010 0.78
47 Seminal vesicle intrafraction motion analysed with cinematic magnetic resonance imaging. Radiat Oncol 2014 0.77
48 Evaluation of dosimetric misrepresentations from 3D conventional planning of liver SBRT using 4D deformable dose integration. J Appl Clin Med Phys 2014 0.77
49 Assessment of out-of-field doses in radiotherapy of brain lesions in children. Int J Radiat Oncol Biol Phys 2010 0.77
50 Real-time in vivo dosimetry with MOSFET detectors in serial tomotherapy for head and neck cancer patients. Int J Radiat Oncol Biol Phys 2011 0.77
51 Pulmonary tumor volume delineation in PET images using deformable models. Conf Proc IEEE Eng Med Biol Soc 2008 0.76
52 The utility of e-Learning to support training for a multicentre bladder online adaptive radiotherapy trial (TROG 10.01-BOLART). Radiother Oncol 2012 0.76
53 The Australian Clinical Dosimetry Service: a commentary on the first 18 months. Australas Phys Eng Sci Med 2012 0.76
54 Comparison of TLD calibration methods for 192Ir dosimetry. J Appl Clin Med Phys 2013 0.76
55 Imaging in the radiotherapy treatment room. J Med Imaging Radiat Oncol 2008 0.75
56 Long term OSLD reader stability in the ACDS level one audit. Australas Phys Eng Sci Med 2014 0.75
57 Interfraction prostate rotation determined from in-room computerized tomography images. Med Dosim 2010 0.75
58 Interpolation and extrapolation of dose measurements with different detector sizes to improve the spatial resolution of radiotherapy dosimetry as demonstrated for helical tomotherapy. Phys Med Biol 2004 0.75
59 Dosimetric Consequences of 3D Versus 4D PET/CT for Target Delineation of Lung Stereotactic Radiotherapy. J Thorac Oncol 2015 0.75
60 A prospective investigation into the clinical impact of 4D-PET/CT in the characterisation of solitary pulmonary nodules. Cancer Imaging 2014 0.75
61 In regard to Anagnostopoulos et al.: In vivo thermoluminescence dosimetry dose verification of transperinal (192)Ir high dose rate brachytherapy using CT-based planning for the treatment of prostate cancer (Int J Radiat Oncol Biol Phys 2003;57:1183-1191). Int J Radiat Oncol Biol Phys 2004 0.75
62 'When measurements mean action' decision models for portal image review to eliminate systematic set-up errors. Australas Radiol 2004 0.75
63 Monitor unit calculation for tangential breast treatments: verification in an anthropomorphic phantom. J Appl Clin Med Phys 2002 0.75
64 Optimal flattening filter shape of a surface brachytherapy applicator. Phys Med Biol 2002 0.75
65 Results of patient specific quality assurance for patients undergoing stereotactic ablative radiotherapy for lung lesions. Australas Phys Eng Sci Med 2014 0.75
66 The influence of field size on stopping-power ratios in- and out-of-field: quantitative data for the BrainLAB m3 micro-multileaf collimator. J Appl Clin Med Phys 2012 0.75
67 Respiratory-gated (4D) FDG-PET detects tumour and normal lung response after stereotactic radiotherapy for pulmonary metastases. Acta Oncol 2015 0.75
68 Feasibility study of multi-pass respiratory-gated helical tomotherapy of a moving target via binary MLC closure. Phys Med Biol 2010 0.75
69 Comparative planning evaluation of intensity-modulated radiotherapy techniques for complex lung cancer cases. Radiother Oncol 2006 0.75
70 Radiotherapy margin design with particular consideration of high curvature CTVs. Med Phys 2009 0.75
71 On the use of Gafchromic EBT3 films for validating a commercial electron Monte Carlo dose calculation algorithm. Phys Med Biol 2015 0.75
72 Adaptive radiotherapy for muscle-invasive bladder cancer: optimisation of plan sizes. J Med Imaging Radiat Oncol 2012 0.75
73 Determination of peripheral underdosage at the lung-tumor interface using Monte Carlo radiation transport calculations. Med Dosim 2011 0.75
74 Correlation of 3D-planned and measured dosimetry of photon and electron craniospinal radiation in a pediatric anthropomorphic phantom. Radiother Oncol 2005 0.75
75 Optimising the dosimetric quality and efficiency of post-prostatectomy radiotherapy: a planning study comparing the performance of volumetric-modulated arc therapy (VMAT) with an optimised seven-field intensity-modulated radiotherapy (IMRT) technique. J Med Imaging Radiat Oncol 2012 0.75
76 Impact of MLC leaf width on the quality of the dose distribution in partial breast irradiation. Med Dosim 2011 0.75
77 Evaluation of EBT radiochromic film using a multiple exposure technique. Australas Phys Eng Sci Med 2011 0.75
78 Online kidney position verification using non-contrast radiographs on a linear accelerator with on board KV X-Ray imaging capability. Med Dosim 2008 0.75
79 The response of prototype plane-parallel ionization chambers in small megavoltage x-ray fields. Med Phys 2006 0.75
80 Computers, p53 and dosimetry: what does this spell? Australas Phys Eng Sci Med 2006 0.75
81 A multileaf collimator phantom for the quality assurance of radiation therapy planning systems and CT simulators. Int J Radiat Oncol Biol Phys 2004 0.75